Bartellella DNA Test

Bartonella bacteria are among the most underdiagnosed infections in medicine. They can live quietly in your bloodstream for weeks or months, causing symptoms that mimic chronic fatigue, unexplained fevers, or swollen lymph nodes, and they almost never show up on the standard blood cultures your doctor would typically order. This test uses PCR (polymerase chain reaction), a technique that amplifies tiny traces of bacterial DNA so they become detectable, to find Bartonella genetic material directly in your blood.

The reason this test matters is straightforward: Bartonella infections can range from a self-limiting case of cat scratch disease to life-threatening heart valve infection (endocarditis), and the usual diagnostic tools are surprisingly poor at catching them. If you have unexplained symptoms after a cat scratch, flea bite, or tick exposure, or if you are immunocompromised and dealing with fevers that no one can explain, this test offers a direct way to look for the bacteria themselves rather than waiting for your immune system to produce antibodies.

What Bartonella DNA (PCR) Actually Detects

This test detects DNA from Bartonella species, most commonly B. henselae (spread by cat scratches and flea bites) and B. quintana (spread by body lice). Unlike antibody tests, which measure your immune system's response to the bacteria and can take six weeks or longer to become positive, PCR finds the organism's genetic material directly. This means it can identify active infection earlier, sometimes before your body has mounted a detectable immune response.

The result is qualitative: positive or negative. A positive result confirms the presence of Bartonella DNA in your blood. A negative result, however, does not rule out infection. Bartonella bacteria circulate in the blood intermittently and at low concentrations, which means the bacteria may simply not have been present in the sample drawn at that moment.

The most common Bartonella infection is cat scratch disease, caused by B. henselae. It typically presents as swollen, painful lymph nodes near a scratch or bite wound, sometimes accompanied by fever and fatigue. In most people with healthy immune systems, it resolves on its own over several weeks. In the only randomized trial of azithromycin for cat scratch disease, half of treated patients (7 of 14) achieved at least 80% reduction in lymph node size by 30 days, compared to just 1 of 15 in the placebo group. That said, antibiotics do not significantly change the cure rate for uncomplicated cases because the condition is usually self-limiting.

The most common Bartonella infection is cat scratch disease, caused by B. henselae. It typically presents as swollen, painful lymph nodes near a scratch or bite wound, sometimes accompanied by fever and fatigue. In most people with healthy immune systems, it resolves on its own over several weeks. A single randomized trial of azithromycin showed that treated patients had about 80% reduction in lymph node size at 30 days compared to placebo. That said, antibiotics do not significantly change the cure rate for uncomplicated cases because the condition is usually self-limiting.

Bartonella is one of the leading causes of culture-negative endocarditis, a serious infection of the heart valves that standard blood cultures fail to detect. B. quintana accounts for roughly 75% of Bartonella endocarditis cases, with B. henselae responsible for most of the remainder. The 2023 Duke-ISCVID criteria now recognize a Bartonella antibody titer of 1:800 or greater as a major diagnostic criterion for endocarditis, and PCR testing of blood or valve tissue offers a complementary route to diagnosis, especially when antibody levels are borderline.

Endocarditis and Severe Infections

Bartonella is one of the leading causes of culture-negative endocarditis, a serious infection of the heart valves that standard blood cultures fail to detect. B. quintana has been identified in roughly 83% of cardiac specimens from confirmed Bartonella endocarditis cases. The 2023 Duke-ISCVID criteria now recognize a Bartonella antibody titer of 1:800 or greater as a major diagnostic criterion for endocarditis, but PCR testing of blood or valve tissue offers a complementary route to diagnosis, especially when antibody levels are borderline.

A U.S. multicenter study of 41 patients with disseminated (widespread) Bartonella infection found a 39% treatment failure rate, underscoring why accurate diagnosis matters. You cannot treat what you have not identified, and Bartonella endocarditis requires prolonged combination antibiotic therapy, typically doxycycline with either rifampin or gentamicin for a minimum of six weeks.

Risk in Immunocompromised Individuals

People with weakened immune systems, particularly those with advanced HIV, organ transplant recipients, or anyone on immunosuppressive medications, face a heightened risk of severe Bartonella disease. In this population, Bartonella can cause bacillary angiomatosis (abnormal blood vessel growths in the skin and organs) and peliosis hepatis (blood-filled cysts in the liver), both of which can be life-threatening if untreated.

PCR testing is especially important for immunocompromised individuals because up to 25% of culture-positive patients with advanced HIV never develop detectable antibodies. In these patients, relying solely on antibody testing means missing one in four infections. PCR bypasses the immune system entirely, detecting the bacteria directly regardless of the patient's ability to mount an antibody response.

How PCR Compares to Antibody Testing

Neither PCR nor antibody testing alone catches every case. In one Italian study of patients with suspected cat scratch disease, PCR identified 16% of cases that antibody testing missed, while antibody testing caught 17% of cases that PCR missed. Combining both methods raised the overall detection rate from about 27-28% (with either test alone) to 44%. For the most thorough evaluation, ordering both Bartonella DNA and Bartonella antibodies together provides the best diagnostic coverage.

What this means for you: if you strongly suspect Bartonella infection, a negative result on any single test should not be the end of the investigation. The combination of PCR and serology, along with your clinical picture, gives the most reliable answer.

Specimen Type Matters

This test uses a blood specimen, which is convenient but carries an important trade-off. Blood-based PCR for Bartonella has approximately 40% sensitivity, meaning it misses more than half of true infections. This is because Bartonella bacteria circulate at very low concentrations and do so intermittently. By comparison, PCR from lymph node pus aspirates (fluid drawn from a swollen lymph node) achieves 96% sensitivity, and testing of primary skin lesions reaches 88%.

If your blood PCR comes back negative but your clinical suspicion remains high, the next step is typically to test tissue from the site of disease, whether that is a lymph node, a skin lesion, or a heart valve specimen. Blood-based PCR is a good first screen because it is minimally invasive, but it should not be treated as the final word.

When Results Can Be Misleading

The single biggest source of false-negative results is the low and intermittent level of Bartonella bacteria in the bloodstream. One study found that among 16 samples previously positive by conventional PCR, 13 came back negative on repeat testing. This is not because the infection resolved; it reflects the challenge of catching these bacteria in a single blood draw.

• Intermittent bacteremia: Bartonella bacteria cycle in and out of detectable levels in the blood. A single negative draw does not rule out infection, especially if clinical suspicion is high.
• PCR inhibitors: Certain substances naturally present in blood or tissue samples can interfere with the PCR reaction, producing a false-negative result even when bacterial DNA is present.
• Cross-amplification: Some PCR assays targeting certain DNA regions can accidentally amplify DNA from related soil bacteria (Mesorhizobium species), potentially producing a false positive. Labs using validated, specific primer sets minimize this risk.
• Antibiotic use: If you have already started antibiotics before the blood draw, the bacterial load in your blood may drop below the detection threshold, leading to a falsely negative result.

Tracking Over Time

Unlike metabolic biomarkers where serial trending reveals a trajectory, Bartonella DNA testing serves a different purpose over time. It is primarily used to confirm diagnosis rather than to monitor treatment response. Once Bartonella infection is diagnosed, treatment response is typically monitored using serial antibody titers (measured at the same lab for consistency) rather than repeat PCR. A fourfold decline in antibody titer is the standard marker of successful treatment.

That said, if your initial blood PCR was negative and your symptoms persist, retesting at a later date can be worthwhile because of the intermittent nature of Bartonella bacteremia. Drawing blood at a different point in the bacterial cycling pattern may catch what the first test missed. If you have an accessible lymph node or skin lesion, testing that tissue directly will give a much higher detection rate than repeated blood draws.